| Literature DB >> 19738931 |
Jodi L Lukkes1, Michael J Watt, Christopher A Lowry, Gina L Forster.
Abstract
Exposure to adverse experiences in early-life is implicated in the later vulnerability to development of psychiatric disorders, including anxiety and affective disorders in humans. Adverse early-life experiences likely impart their long-term consequences on mental health by disrupting the normal development of neural systems involved in stress responses, emotional behavior and emotional states. Neural systems utilizing the neurotransmitters serotonin, dopamine and the neuropeptide corticotropin-releasing factor (CRF) are implicated in mediating emotive behaviors, and dysfunction of these neurochemical systems is associated with mood/anxiety disorders. These neural systems continue maturing until early or mid-adolescence in humans, thus alterations to their development are likely to contribute to the long-term consequences of adverse early-life experiences. A large body of literature suggests that post-weaning isolation rearing of rodents models the behavioral consequences of adverse early-life experiences in humans. Overall, the majority findings suggest that post-weaning social isolation that encompasses pre-adolescence produces long-lasting alterations to anxiety behavior, while measures of monoaminergic activity in various limbic regions during social isolation suggest alterations to dopamine and serotonin systems. The goal of this review is to evaluate and integrate findings from post-weaning social isolation studies specifically related to altered fear and anxiety behaviors and associated changes in neuroendocrine function and the activity of monoaminergic systems.Entities:
Keywords: CRF; anxiety; dopamine; fear; isolation; rat; serotonin; stress
Year: 2009 PMID: 19738931 PMCID: PMC2737489 DOI: 10.3389/neuro.08.018.2009
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Effects of isolation rearing on serotonergic function within anxiety-related neural circuits.
| Brain region | Length of Isolation | Species/strain | Effect |
|---|---|---|---|
| PD30-PD110 | Gerbils | Overshoot of 5-HT innervations in the entorhinal, insular, and cingulate (layers II and III) cortices (Neddens et al., | |
| PD21-PD70 | Sprague-Dawley rats | ↑ 5-HT turnover but no effect on 5-HT levels (Brenes et al., | |
| PD42-PD126 | NMRI mice | ↓ 5-HT concentrations (Rilke et al., | |
| PD49-PD77 | F344 rats | ↑ 5-HT levels (Miura et al., | |
| PD42-PD105 | NMRI mice | ↑ 5-HT1A and 5-HT2A receptor binding, attenuated by citalopram (Gunther et al., | |
| PD1-PD45 | Degus | ↑ 5-HT fiber densities in the infralimbic cortex (Braun et al., | |
| PD28-PD56 | Lister-hooded rats | No effect on 5-HT levels (Dalley et al., | |
| PD21-PD105; PD21-PD63 | Lister-hooded rats | ↓ 5-HT release (Jones et al., | |
| PD28-PD100;PD21-PD70 | Sprague-Dawley rats | ↓ 5-HT levels or no effect, but ↑ 5-HT turnover (Brenes et al., | |
| PD21-PD51;PD42-84 | Wistar rats; NMRI mice | ↑ gene expression of 5-HT1A receptors (Del-Bel et al., | |
| PD22-PD64 | Sprague-Dawley rats | ↓ 5-HT fiber innervation from the dRN (Whitaker-Azmitia et al., | |
| PD49-PD77 | F344 rats | ↑ 5-HT levels (Miura et al., | |
| PD42-PD126; PD42-PD105 | NMRI mice | ↓ 5-HT concentrations (Rilke et al., | |
| PD49-PD77 | F344 rats | ↑ 5-HT levels and turnover in response to novelty (Miura et al., | |
| PD42-PD126 | NMRI mice | ↓ 5-HT concentrations (Rilke et al., | |
| PD28-PD100 | Sprague-Dawley rats | ↑ 5-HT concentrations, restored by fluoxetine (Brenes and Fornaguera, | |
| PD21-PD63 | Lister-hooded rats | ↑ NAc shell 5-HT release during unconditioned and conditioned foot-shock (Fulford and Marsden, | |
| PD21-PD105 | Lister-hooded rats | ↓ 5-HT release (Jones et al., | |
| PD42-PD105 | NMRI mice | ↑ 5-HT2A receptor binding in NAc core, attenuated by citalopram (Gunther et al., | |
| PD21-PD105 | Wistar rats | ↓ 5-HT turnover (Heidbreder et al., | |
| PD30-PD110 | Gerbils | No alterations in 5-HT innervation (Lehmann et al., | |
| PD21-PD42; re-socalized until testing (PD56) | ↑ 5-HT release stimulated by corticotrop in-releasing factor (Lukkes et al., | ||
| PD42-PD105 | NMRI mice | ↑ 5-HT1A receptor binding in the cortical amygdala, not attenuated by citalopram (Gunther et al., | |
| PD30-PD110 | Gerbils | ↑ 5-HT innervation of the CeA and BLA (Lehmann et al., | |
| PD1-PD45 | Degus | ↑ density of 5-HT fibers in CeA (Gos et al., |
Animals were tested on the last day of isolation-rearing unless otherwise stated.
Control groups comprised group-reared animals.
Effects of isolation rearing on dopaminergic function within anxiety-related neural circuits.
| Brain region | Length of Isolation | Species/strain | Effect |
|---|---|---|---|
| PD42-PD49 | NMRI mice | ↑ DA metabolism (Rilke et al., | |
| PD1-PD45 | Degus | ↓ DA fibers in the precentral medial cortex, anterior cingulate cortex, and prelimbic cortex (Braun et al., | |
| PD49-PD77 | F344 rats | No effect on DA levels (Miura et al., | |
| PD28-PD56 | Lister-hooded rats | No effect on DA levels (Dalley et al., | |
| PD30-PD90 | Gerbils | ↓ DA innervation (Winterfeld et al., | |
| PD21-PD105 | Lister-hooded and Wistar rats | ↓ DOPAC, HVA, DA turnover, but ↑ DA levels and concentrations (Weinstock et al., | |
| PD21-PD111 | Nerr1-NULL mice | ↓ DA and DOPAC levels (Eells et al., | |
| PD21-PD385 | Sprague-Dawley rats | No effect on DA release (Leng et al., | |
| PD49-PD77 | F344 rats | No effect on DA levels (Miura et al., | |
| PD28-PD100 | Sprague-Dawley rats | ↑ DA turnover (Brenes and Fornaguera, | |
| PD21-PD40 | Lister-hooded rats | ↑ D2 DA receptors (King et al., | |
| PD49-PD77 | F344 rats | ↑ DA levels (Miura et al., | |
| PD21-PD63 | Lister-hooded rats | ↑ NAc shell DA release during unconditioned and conditioned foot-shock (Fulford and Marsden, | |
| PD21-PD105 | Lister-hooded rats | ↑ amphetamine-induced release of DA (Jones et al., | |
| PD21-PD105 | Lister-hooded and Wistar rats | ↑ DA turnover (Hall et al., | |
| PD21-PD105 | Lister-hooded rats | ↓ DOPAC, HVA, and DA turnover, but ↑ DA levels (Weinstock et al., | |
| PD28-PD100 | Sprague-Dawley rats | No effect on DA levels (Brenes and Fornaguera, | |
| PD21-PD105 | Lister-hooded rats | ↓ D2 DA receptors (Hall et al., | |
| PD21-PD105; PD21-PD81 | Lister-hooded, Sprague-Dawley, and Fawn-Hooded rats | No alterations in D1 or D2 DA receptors (Wilmot et al., | |
| PD21-PD111 | Nerr1-NULL mice | ↓ DA levels and ↑ DA turnover (Eells et al., | |
| PD42-PD126 | NMRI mice | No effect on D2 DA receptors or DA metabolism (Rilke et al., | |
| PD21-PD105 | Lister-hooded and Wistar rats | ↑ DA turnover (Hall et al., |
Animals were tested on the last day of isolation-rearing.
Control groups comprised group-reared animals.